Last updated on March 2020

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health


Brief description of study

The purpose of this study is to assess the safety, reactogenicity, and immunogenicity of 3 different doses of ExPEC10V and to select the optimal dose for further clinical development (Cohort 1). Cohort 2 is aimed to expand the dataset supporting the short- and long-term safety and immunogenicity of the optimal dose of ExPEC10V, selected from the primary analysis results of Cohort 1. Cohort 2 will include participants in stable health with a history of urinary tract infection (UTI) in the past 5 years and will be included in the study to support the plan for late stage development of ExPEC10V.

Clinical Study Identifier: NCT03819049

Find a site near you

Start Over

Qps-Mra, Llc

Miami, FL United States
  Connect »

Coastal Carolina Research Center

Mount Pleasant, SC United States
  Connect »

Optimal Research

Melbourne, FL United States
  Connect »

Optimal Research

Peoria, IL United States
  Connect »

Anima

Alken, Belgium
  Connect »